About the Overcoming Drug Resistance and Toxicity Session
Overcoming drug resistance and toxicity remains a major challenge in cancer therapy. Resistance arises from genetic mutations in cancer cells, leading to treatment inefficacy, while toxicity affects patients’ quality of life. Strategies to address these issues include combination therapies, sequential treatment regimens, and next-generation drugs designed to bypass resistance mechanisms. Biomarker-driven approaches allow for better prediction of drug responses, enabling personalized treatment plans. Advances in nanotechnology and drug design continue to mitigate toxicity, ensuring safer and more effective cancer treatments for patients worldwide.
Topics Covered in Overcoming Drug Resistance and Toxicity
Resistance Mechanisms
Drug Efflux Pumps
Combination Regimens
Next-Generation Inhibitors
Dose Optimization
Pharmacogenomic Testing
Related Scientific Sessions at CIOC 2027
Why Attend the Overcoming Drug Resistance and Toxicity Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Overcoming Drug Resistance and Toxicity work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Overcoming Drug Resistance and Toxicity research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Overcoming Drug Resistance and Toxicity track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Overcoming Drug Resistance and Toxicity Conference 2027 — FAQs
What is the Overcoming Drug Resistance and Toxicity track at CIOC 2027?
The Overcoming Drug Resistance and Toxicity track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Overcoming Drug Resistance and Toxicity. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Overcoming Drug Resistance and Toxicity sessions?
Cancer researchers and clinicians, educators and students with an interest in Overcoming Drug Resistance and Toxicity are all welcome — whether presenting or attending.
Can I present my research in the Overcoming Drug Resistance and Toxicity track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Overcoming Drug Resistance and Toxicity sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Overcoming Drug Resistance and Toxicity track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.